跳至主要内容
临床试验/IRCT2015113025292N1
IRCT2015113025292N1已完成2 期

Adding Ofloxacin to standard regimens versus standard triple-drug regimens consist of Clarithromycin, Amoxicillin, and Rabeprazole for Helicobacter Pylori Infection among patients with gastrointestinal problems based on Helicobacter pylori

Vice chancellor for research, Babol University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • positive biopsies of H. pylori; positive rapid urease test of H. pylori, stomach ulcer; duodenal ulcer; dyspepsia with indications of Helicobacter pylori eradication.
  • Exclusion criteria: previous treatment for H. pylori; renal failure; receiving antibiotics during the previous last month; cirrhosis; pregnancy; breast feeding; gastric cancer.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Babol University of Medical Sciences

相似试验

Efficacy of Ofloxacin in eradication of Helicobacter... | 临床试验